Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Silymarin in metastatic colorectal cancer
NCT05631041Phase 3Recruiting
- Sponsor
- Tanta University
- Start
- Dec 2022
- Primary completion
- Nov 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of silymarin in metastatic colorectal cancer (mCRC), sponsored by Tanta University. Started Dec 2022; status: recruiting.
02
Drugs
silymarin
03
Conditions
metastatic colorectal cancer (mCRC)
Beyond the preview
Go deeper on NCT05631041.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05631041.